Lothar Bergmann

6.7k total citations
182 papers, 4.8k citations indexed

About

Lothar Bergmann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lothar Bergmann has authored 182 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 64 papers in Pulmonary and Respiratory Medicine and 48 papers in Oncology. Recurrent topics in Lothar Bergmann's work include Renal cell carcinoma treatment (54 papers), Renal and related cancers (48 papers) and Lymphoma Diagnosis and Treatment (30 papers). Lothar Bergmann is often cited by papers focused on Renal cell carcinoma treatment (54 papers), Renal and related cancers (48 papers) and Lymphoma Diagnosis and Treatment (30 papers). Lothar Bergmann collaborates with scholars based in Germany, United Kingdom and France. Lothar Bergmann's co-authors include Eckhart Weidmann, Ulrich Maurer, D. Hoelzer, T. Karakas, Jürgen Brieger, Paris S. Mitrou, Michael Morgan, Christoph Reuter, Luise Maute and Dieter Hoelzer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Lothar Bergmann

170 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lothar Bergmann Germany 39 2.1k 1.4k 1.4k 1.0k 813 182 4.8k
Lia Gore United States 43 2.6k 1.2× 1.1k 0.8× 2.6k 1.9× 743 0.7× 821 1.0× 202 6.1k
P. Maslak United States 32 2.8k 1.4× 1.7k 1.2× 3.1k 2.3× 1.1k 1.0× 575 0.7× 116 6.3k
Ulrich Jäger Austria 45 1.8k 0.9× 2.4k 1.7× 1.7k 1.2× 1.2k 1.1× 276 0.3× 172 5.7k
Philippe Martiat Belgium 38 2.0k 1.0× 1.6k 1.1× 1.3k 1.0× 932 0.9× 394 0.5× 110 5.6k
Dina Ben‐Yehuda Israel 35 2.1k 1.0× 1.7k 1.2× 1.3k 1.0× 579 0.6× 432 0.5× 124 4.8k
Joseph O. Moore United States 42 1.8k 0.9× 3.3k 2.4× 1.9k 1.4× 962 0.9× 552 0.7× 148 6.6k
Martin F. Fey Switzerland 49 3.1k 1.5× 2.1k 1.5× 3.0k 2.2× 1.0k 1.0× 955 1.2× 189 8.0k
Sung‐Soo Yoon South Korea 35 1.6k 0.8× 1.8k 1.3× 1.5k 1.1× 630 0.6× 313 0.4× 342 4.2k
Kiyohiko Hatake Japan 41 1.3k 0.6× 603 0.4× 2.3k 1.7× 1.2k 1.2× 736 0.9× 237 5.1k
Didier Bouscary France 40 3.5k 1.7× 2.3k 1.6× 1.4k 1.0× 993 1.0× 390 0.5× 163 6.3k

Countries citing papers authored by Lothar Bergmann

Since Specialization
Citations

This map shows the geographic impact of Lothar Bergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Bergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Bergmann more than expected).

Fields of papers citing papers by Lothar Bergmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Bergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Bergmann. The network helps show where Lothar Bergmann may publish in the future.

Co-authorship network of co-authors of Lothar Bergmann

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Bergmann. A scholar is included among the top collaborators of Lothar Bergmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Bergmann. Lothar Bergmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osinga, Thamara E., Sjoukje F. Oosting, Peter van der Meer, et al.. (2022). Immune checkpoint inhibitor–associated myocarditis. Netherlands Heart Journal. 30(6). 295–301. 13 indexed citations
2.
Goebell, Peter J., Christian Doehn, Norbert Marschner, et al.. (2019). Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study. Oncology Research and Treatment. 42(1-2). 57–66. 2 indexed citations
3.
Donskov, Frede, Robert J. Motzer, Éric Voog, et al.. (2017). Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in patients with advanced renal cell carcinoma (RCC).. Journal of Clinical Oncology. 35(6_suppl). 517–517. 2 indexed citations
4.
Bergmann, Lothar, Luise Maute, Gerhard Heil, et al.. (2014). A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer. European Journal of Cancer. 51(1). 27–36. 51 indexed citations
5.
Hartmann, Sylvia, Claudio Agostinelli, Jürgen Diener, et al.. (2012). GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers. BMC Cancer. 12(1). 586–586. 25 indexed citations
6.
Schultheis, Beate, Dirk Strumberg, Lothar Bergmann, et al.. (2011). Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group). Investigational New Drugs. 30(3). 1184–1192. 12 indexed citations
7.
Bergmann, Lothar, et al.. (2008). Las pinturas rupestres de la sierra del Retín, Barbate (Cádiz). 36(36). 9–20. 2 indexed citations
8.
McCabe, Christopher, Lothar Bergmann, Nicholas Bosanquet, et al.. (2008). Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective. Annals of Oncology. 20(3). 403–412. 52 indexed citations
9.
Bergmann, Lothar. (2006). Arte sureño: Nuevos descubrimientos y situación actual del arte rupestre del extremo sur de la Península Ibérica. 117–124. 1 indexed citations
10.
Hofmann, W.-K., Gerhard Heil, Stephanie A. Wiebe, et al.. (2004). Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia. Annals of Hematology. 83(8). 498–503. 44 indexed citations
11.
Schirrmeister, Holger, Andreas K. Buck, Lothar Bergmann, Sven N. Reske, & Martin Bommer. (2003). Positron Emission Tomography (PET) for Staging of Solitary Plasmacytoma. Cancer Biotherapy and Radiopharmaceuticals. 18(5). 841–845. 85 indexed citations
12.
Buchmann, Inga, S N Reske, J. Kotzerke, et al.. (2000). Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation. Blood. 96(11). 1 indexed citations
13.
Munzert, Gerd, et al.. (2000). Normal Structure of NFKB 2, C-REL and BCL-3 Gene Loci in Lymphoproliferative and Myeloproliferative Disorders. Leukemia & lymphoma. 38(3-4). 395–400. 9 indexed citations
14.
Rummel, Mathias, Kai Uwe Chow, Elke Jäger, et al.. (1999). Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse. Annals of Oncology. 10(1). 115–118. 19 indexed citations
15.
Weidmann, Eckhart, Alexander Schmidt, Lothar Bergmann, et al.. (1999). The effects of interleukin‐2 treatment on endothelin and the activation of the hypothalamic–pituitary–adrenal axis. Clinical Endocrinology. 50(1). 37–44. 13 indexed citations
16.
Rummel, Mathias, Michael Schenk, Alexander Knuth, et al.. (1997). Fludarabine Plus Epirubicin in Untreated or Minimal Pretreated Patients with Chronic Lymphocytic Leukemia – Preliminary Results of a Phase-ll Study. Oncology Research and Treatment. 20(4). 328–331. 1 indexed citations
17.
Jahn, Bernhard, Lothar Bergmann, Eckhart Weidmann, et al.. (1995). Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity. Leukemia Research. 19(2). 73–82. 24 indexed citations
18.
Weidmann, Eckhart, Jürgen Brieger, Bernhard Jahn, et al.. (1995). Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia. Annals of Hematology. 70(3). 153–158. 5 indexed citations
19.
Bergmann, Lothar. (1995). Nuevas cuevas con pinturas rupestres en el término municipal de Tarifa. 51–64.
20.
Fenchel, Klaus, et al.. (1994). Fludarabine is an Effective Agent in Immunocytic Lymphoma. Oncology Research and Treatment. 17(5). 508–513. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lia Gore Breakdown of academic impact, for papers by P. Maslak Breakdown of academic impact, for papers by Ulrich Jäger Breakdown of academic impact, for papers by Philippe Martiat Breakdown of academic impact, for papers by Dina Ben‐Yehuda Breakdown of academic impact, for papers by Joseph O. Moore Breakdown of academic impact, for papers by Martin F. Fey Breakdown of academic impact, for papers by Sung‐Soo Yoon Breakdown of academic impact, for papers by Kiyohiko Hatake Breakdown of academic impact, for papers by Didier Bouscary
Rankless by CCL
2026